LAHRS Content 2023-LAHRS/HRS Joint Session Update in Common Problems

Video Transcription

Video Summary

In the given video transcript, Dr. Judy Hurwitz discussed the challenges and considerations in anticoagulation for atrial fibrillation to prevent stroke. She highlighted the limitations of using ejection fraction, functional class, and duration of atrial fibrillation as sole criteria for risk stratification. Dr. Hurwitz pointed out that new pharmacological treatments like secubitril and glyphosate have shown potential in reducing ventricular arrhythmias and sudden death. She mentioned ongoing studies like REACT to evaluate targeted NOAC therapy and emphasized the importance of personalized approaches for patient management. Additionally, Dr. Luis Aguinaga focused on risk stratification for sudden cardiac death in patients with ischemic heart disease, highlighting the inadequacies of current guidelines based on older evidence. He discussed the importance of new tools, including electrocardiogram abnormalities, cardiac MRI, biomarkers like NT-proBNP, and polygenic risk scores in improving risk assessment. Dr. Aguinaga emphasized the need for a personalized approach and shared decision-making to effectively identify patients who would benefit most from interventions to prevent sudden death.

Keywords

anticoagulation

atrial fibrillation

stroke prevention

risk stratification

ventricular arrhythmias

pharmacological treatments

NOAC therapy

sudden cardiac death

ischemic heart disease

personalized approach